Jonathan Zaroff is a Cardiology physician affiliated with Kaiser Permanente. OpenAlex indexes 171 publications with 7,532 citations (h-index 44).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
350 Parnassus Ave
San Francisco, CA 941173608
Telephone
415-353-2873Registry record last updated 22 Dec 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20252 payments
- Abbott LaboratoriesProgram year20249 payments
- Edwards Lifesciences CorporationProgram year20227 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.6%Beta blocker19.6%Metoprolol Succinate70%Carvedilol20%Metoprolol Tartrate11%Part D≥55 patientsStatin17.6%Atorvastatin Calcium76%Rosuvastatin Calcium18%Simvastatin7%Part D<11 patients+ 12 more classes in this area
Blood & clotting
6.1%Direct thrombin inhibitors3.5%Pradaxa100%Part D≥16 patientsP2Y12 inhibitor1.5%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.5%SGLT2 inhibitor1.4%Jardiance100%Part D<11 patientsProton pump inhibitor1.1%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2000–2006 per NIH RePORTER. The latest:
- Risk factors for cardiac injury after SAH
University of California, San Francisco
FY2006$136,844R21NS050551 - Risk factors for cardiac injury after SAH
University of California San Francisco
FY2005$175,172R21NS050551 - VENTRICULAR DYSFUNCTION AFTER SUBARACHNOID HEMORRHAGE
University of California San Francisco
FY2004$121,770K23HL004054
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation
Journal of the American College of Cardiology
2019 - National Decline in Donor Heart Utilization With Regional Variability: 1995-2010
American Journal of Transplantation
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Presti, MD
Kaiser Permanente
Walter Kinney, MD
Kaiser Permanente
Alexander Flint, MD, PhD
Kaiser Permanente
Eric Macy, MD
Kaiser Permanente
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”